Psoriatic Disease

Ethan Craig, MD, spoke with Healio about diagnostic challenges in psoriatic arthritis.

The FDA has approved 320 mg pre-filled syringes and autoinjectors of Bimzelx for the treatment of active psoriatic arthritis with coexisting moderate-to-severe plaque psoriasis, according to a press release from UCB.

Treatment with apremilast led to improved clinical and patient-reported outcomes in early oligoarticular psoriatic arthritis at 16 weeks, according to data published in Annals of the Rheumatic Diseases.

SAN DIEGO — Certain dual therapy strategies, including interleukin-17 plus IL-23 inhibition, or Janus kinase inhibitors alongside TNF inhibitors, can be effective for difficult-to-treat inflammatory diseases, according to a speaker here.

SAN DIEGO — GLP-1 agonists and other drugs that have recently made headlines for their weight loss applications will be useful in helping patients meet goals in psoriatic arthritis and other rheumatic diseases, according to a speaker here.

PHILADELPHIA — Members of the psoriatic disease community recently gathered at the Philadelphia Zoo to raise funds that will be used to support patients through research and advocacy.

The 28-joint Disease Activity Index for Psoriatic Arthritis score is superior to the DAS28-CRP score as a measure of disease activity in PsA if the “gold standard” DAPSA 66/68 joint counts are not available, according to data.

The FDA has expanded the indication of Bimzelx to include psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis with objective signs of inflammation, according to a press release.

The National Psoriasis Foundation has announced the honorees for this year’s Commit to Cure Gala, according to a press release.

Blue-collar workers with psoriatic arthritis demonstrate an increased risk for work disability vs. white-collar workers with the same disease, according to data published in Clinical Rheumatology.